Palvella Therapeutics PVLA Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Palvella Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's quick ratio?
- Palvella Therapeutics (PVLA) reported quick ratio of 28.9× in Q1 2026.
- How has Palvella Therapeutics's quick ratio changed year-over-year?
- Palvella Therapeutics's quick ratio increased by 226.6% year-over-year, from 8.8× to 28.9×.
- What is the long-term trend for Palvella Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Palvella Therapeutics's quick ratio has grown at a 8.7% compound annual growth rate (CAGR), from 3.4× to 5.2×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.